상세 가이드 곧 제공 예정
Radiation Dose Equivalent Calculator에 대한 종합 교육 가이드를 준비 중입니다. 단계별 설명, 공식, 실제 예제 및 전문가 팁을 곧 확인하세요.
Radiation dose equivalence is the scientific framework for comparing the biological harm potential of different types of ionising radiation, accounting for both the energy deposited and the intrinsic capacity of each radiation type to damage biological tissue. The absorbed dose — measured in Gray (Gy), defined as 1 joule of energy deposited per kilogram of tissue — quantifies physical energy deposition but does not distinguish between radiation types of very different biological effectiveness. To account for this, the equivalent dose (measured in Sievert, Sv) is calculated by multiplying the absorbed dose by a radiation weighting factor (W_R, formerly called quality factor Q) that reflects the relative biological effectiveness of each radiation type: photons (X-rays, gamma rays) have W_R = 1; protons = 2; neutrons = 2.5–20 (energy-dependent); alpha particles = 20; heavy ions = 20. Thus, 1 Gy of alpha radiation causes the same biological harm as 20 Gy of X-rays (20 Sv equivalent dose). A further step — effective dose in Sievert — accounts for tissue radiosensitivity by multiplying equivalent doses to each organ by tissue weighting factors (W_T) defined by ICRP Publication 103 (2007), producing a whole-body risk estimate useful for regulatory limits and risk communication. Common exposure benchmarks provide crucial clinical and public health context: a chest X-ray delivers approximately 0.02 mSv; a CT abdomen/pelvis approximately 10 mSv; annual background radiation in the UK approximately 2.7 mSv; occupational exposure limit for radiation workers is 20 mSv per year (averaged over 5 years); a CT full-body survey approximately 15–20 mSv; therapeutic radiation for cancer typically 45–80 Gy delivered to a limited tissue volume. Understanding these dose quantities, their relationships, and their biological significance allows oncologists, radiologists, radiation physicists, and public health practitioners to communicate radiation risk clearly and accurately.
Absorbed dose (Gy) = Energy deposited (J) ÷ Mass (kg); Equivalent dose (Sv) = Absorbed dose (Gy) × Radiation weighting factor (W_R); Effective dose (Sv) = Sum of [Equivalent dose to organ × Tissue weighting factor W_T]; Radiation weighting factors: X-rays/gamma = 1; protons = 2; neutrons = 2.5–20; alpha = 20; heavy ions = 20
- 1Measure or calculate the absorbed dose in Gray (Gy) using dosimetry: thermoluminescent dosimeters (TLDs), ionisation chambers, or Monte Carlo simulation models. 1 Gy = 1 joule per kilogram of tissue = 100 rad (older CGS unit).
- 2Identify the radiation type and assign the appropriate ICRP radiation weighting factor (W_R): X-rays, gamma rays, electrons = W_R 1; protons = 2; neutrons vary from 2.5 (very low energy) to 20 (fast neutrons, 1–2 MeV); alpha particles and heavy ions = 20.
- 3Calculate equivalent dose in Sievert: Equivalent Dose (Sv) = Absorbed Dose (Gy) × W_R. For low-LET radiation (X-rays, gamma), 1 Gy = 1 Sv. For alpha particles, 1 Gy = 20 Sv equivalent dose.
- 4For whole-body risk assessment, calculate effective dose by summing over all exposed organs: Effective Dose (Sv) = Σ [H_T × W_T], where H_T is the equivalent dose to each organ and W_T is the organ-specific tissue weighting factor from ICRP 103 (e.g., breast W_T = 0.12; lung = 0.12; thyroid = 0.04; bone marrow = 0.12; gonads = 0.08).
- 5Compare the calculated dose to known reference benchmarks: background radiation (~2.7 mSv/yr in UK); annual occupational limit (20 mSv/yr); occupational lifetime limit (1000 mSv career average); diagnostic threshold for deterministic effects (typically >100 mGy whole body); cancer radiotherapy dose (45–80 Gy tumour dose in fraction).
- 6Assess biological risk using stochastic (probabilistic) risk models: BEIR VII (2006) estimates lifetime cancer mortality risk as approximately 5% per Sv (0.005% per mSv) for low-dose radiation in the general population. This linear no-threshold (LNT) model is used for regulatory purposes though its applicability at very low doses (<100 mSv) is debated.
- 7Apply occupational exposure monitoring: radiation workers wear personal dosimeters (film badge, TLD, or electronic personal dosimeters) that are read monthly or quarterly; annual occupational dose limit is 20 mSv/year averaged over 5 years, not exceeding 50 mSv in any single year, per ICRP 103.
Chest X-ray is one of the lowest-dose medical imaging procedures available.
At 0.02 mSv, the theoretical lifetime cancer risk from a single chest X-ray is approximately 1 in 1,000,000 — far below the natural cancer risk of 1 in 3.
A modern multidetector CT has a higher effective dose than older CT models but substantially better image quality and diagnostic yield.
At 10 mSv, the theoretical lifetime cancer risk is approximately 1 in 2,000 — clinically very small but noteworthy when considering cumulative CT exposure in young patients or serial surveillance imaging.
Internal alpha emitters (radon gas, plutonium, polonium-210) deliver high equivalent doses to small tissue volumes despite relatively low absorbed dose.
This illustrates why alpha-emitting internal contamination is extremely dangerous — radon gas is the second leading cause of lung cancer after smoking, despite emitting 'only' alpha particles that cannot penetrate skin but cause severe local ionisation within the lung epithelium.
ALARA = As Low As Reasonably Achievable; occupational exposure should be optimised below limits, not simply kept under the limit.
Radiation workers should aim for the lowest practicable dose through time, distance, and shielding optimisation — the limit represents a regulatory maximum, not a target.
Radiologists and radiographers use dose area product (DAP) and effective dose estimates to justify imaging requests and report cumulative dose to referring clinicians for high-exposure patients., where accurate radiation dose equivalent analysis through the Radiation Dose Equivalent supports evidence-based decision-making and quantitative rigor in professional workflows
Radiation oncology physicists calculate equivalent and effective doses to organs at risk (heart, lung, spinal cord) from treatment plans to predict late toxicity and optimise treatment delivery., where accurate radiation dose equivalent analysis through the Radiation Dose Equivalent supports evidence-based decision-making and quantitative rigor in professional workflows
Occupational health departments monitor radiation worker dosimeter readings against annual limits and conduct dose investigation when limits are approached, implementing ALARA measures., where accurate radiation dose equivalent analysis through the Radiation Dose Equivalent supports evidence-based decision-making and quantitative rigor in professional workflows
Public health authorities use effective dose data to estimate population cancer risk from diagnostic imaging nationally and to promote dose optimisation initiatives such as Image Gently and Image Wisely., where accurate radiation dose equivalent analysis through the Radiation Dose Equivalent supports evidence-based decision-making and quantitative rigor in professional workflows
Nuclear power and industrial radiology organisations use equivalent dose calculations for regulatory compliance, worker protection, and accident consequence assessment following radiological incidents.
Radiation in pregnancy
Fetal radiation sensitivity is highest in the first trimester (organogenesis) and significant throughout the first 25 weeks. Deterministic effects (growth retardation, malformation) require threshold doses >100–200 mGy to the fetus. Most diagnostic CT scans deliver <50 mGy to the fetus. At doses <50 mGy, the International Commission on Radiological Protection considers the risk of fetal harm negligible and imaging should not be withheld when clinically indicated.
ALARA — As Low As Reasonably Achievable
ALARA is the governing principle of radiation protection, requiring that occupational and public exposures are reduced to the lowest level achievable with reasonable practical effort and expense. It applies to diagnostic imaging (minimum necessary dose for diagnostic quality images), occupational exposure (shielding, distance, time minimisation), and nuclear medicine procedures (lowest effective radiopharmaceutical activity).
Paediatric dose considerations
Children are more radiosensitive than adults due to rapidly dividing cells, longer life expectancy (more time for latent cancers to develop), and smaller body size (higher dose per organ from the same radiation field). Paediatric CT protocols must be size-adapted — the ALARA principle applies especially strictly in children. The Image Gently campaign promotes dose optimisation in paediatric imaging globally.
Radiopharmaceuticals and nuclear medicine
Nuclear medicine procedures (PET, SPECT, scintigraphy) use internally administered radiopharmaceuticals that emit gamma radiation detectable externally. Effective doses range from 1 mSv (bone scan) to 20+ mSv (whole-body PET-CT with FDG). Radiation workers in nuclear medicine departments are at risk of internal contamination from radionuclide aerosols and require bioassay monitoring alongside external dosimetry.
| Radiation Source | Effective Dose (mSv) | Background Equivalent | Lifetime Cancer Risk (LNT) |
|---|---|---|---|
| Chest X-ray (PA) | 0.02 | 3 days | ~1 in 1,000,000 |
| Dental X-ray | 0.005 | <1 day | Negligible |
| Mammogram (2-view) | 0.4 | 7 weeks | ~1 in 50,000 |
| CT head | 2 | 8 months | ~1 in 10,000 |
| CT chest | 7 | 2.6 years | ~1 in 3,000 |
| CT abdomen/pelvis | 10 | 3.7 years | ~1 in 2,000 |
| CT full body | 15–20 | 5–7 years | ~1 in 1,000 |
| Annual background (UK) | 2.7 | — | ~1 in 7,400 cumulative |
| Occupational limit | 20 mSv/year | ~7 years background | ~1 in 1,000 per year at limit |
| Radiotherapy (tumour dose) | 45,000–80,000 mGy (local) | N/A (localised) | N/A (treatment intent) |
What is the difference between Gray and Sievert?
Gray (Gy) measures absorbed dose — the physical energy deposited in tissue per kilogram (1 Gy = 1 J/kg = 100 rad). Sievert (Sv) measures equivalent or effective dose — the biologically weighted dose that accounts for radiation type (W_R) and organ sensitivity (W_T). For X-rays and gamma rays, 1 Gy = 1 Sv. For alpha particles, 1 Gy = 20 Sv. Gray is used in radiotherapy dosimetry; Sievert is used in radiation protection and risk communication.
What is background radiation?
Background radiation is the naturally occurring ionising radiation exposure received by the general population from: cosmic radiation (0.3 mSv/year at sea level; higher at altitude); terrestrial gamma radiation from soil and building materials (0.5 mSv/year average); radon gas inhalation (1.3 mSv/year in UK — by far the largest contributor); and internal body radionuclides (potassium-40, carbon-14). Total average UK background dose ≈ 2.7 mSv/year; higher in granite-rich regions (e.g., Cornwall, Aberdeen).
What is the linear no-threshold (LNT) model?
The LNT model assumes that any radiation dose, no matter how small, carries a proportional risk of cancer. It extrapolates risk from high-dose observations (atomic bomb survivor data) down to zero, without a threshold below which risk is zero. The LNT model is used for radiation protection regulation but is scientifically contested at very low doses (<100 mSv) where some evidence suggests the risk may be negligible or DNA repair mechanisms may eliminate harm.
What annual dose is safe for radiation workers?
ICRP (2007) recommends: occupational dose ≤20 mSv/year averaged over any 5-year period, with no single year exceeding 50 mSv; eye lens dose ≤20 mSv/year; skin dose ≤500 mSv/year; hands/feet ≤500 mSv/year. These limits are implemented by regulation in the UK (Ionising Radiations Regulations 2017), EU (BSS Directive 2013/59/Euratom), and US (10 CFR Part 20 — NRC).
What dose is required to cause acute radiation syndrome?
Acute radiation syndrome (ARS) requires a whole-body absorbed dose of >0.7–1.0 Gy delivered over a short period. Above 1 Gy: haematopoietic syndrome (bone marrow suppression, immunosuppression); >6 Gy: gastrointestinal syndrome; >10 Gy: neurovascular syndrome (lethal within days even with treatment). Partial-body exposures in radiotherapy routinely exceed these doses locally without causing ARS because the treatment is localised and fractionated.
How do radiotherapy doses compare to diagnostic imaging doses?
Diagnostic imaging delivers effective doses in the range of 0.02 mSv (CXR) to 20 mSv (CT full body). Therapeutic radiotherapy delivers absorbed doses to the tumour of 45–80 Gy — three to four orders of magnitude higher than a CT scan — but localised to a small tissue volume over 4–8 weeks of fractionated treatment. The localisation and fractionation are what make therapeutic doses survivable while eradicating tumour cells.
Is background radiation from radon a significant cancer risk?
Yes. Radon (Rn-222) is a naturally occurring radioactive gas that accumulates in poorly ventilated buildings and contributes approximately 1.3 mSv/year of lung dose in the UK on average. High-radon areas (Cornwall, Derbyshire Peak District, Devon) can have exposures of 100–200 mSv/year from radon alone. Public Health England estimates radon causes approximately 1100 lung cancer deaths annually in the UK — 5% of all lung cancer deaths.
What are the radiation weighting factors for common radiation types?
ICRP 103 (2007) W_R values: photons (all energies) = 1; electrons/muons = 1; protons/charged pions = 2; alpha particles, heavy ions = 20; neutrons (energy-dependent) = 2.5 (thermal <10 keV) to 20 (1 MeV), then declining to 5 (>50 MeV). These values reflect relative biological effectiveness based on ionisation density (linear energy transfer, LET): high-LET radiation causes denser ionisation tracks with more complex, less repairable DNA damage.
전문가 팁
When explaining radiation dose to patients, use the concept of 'background radiation equivalent' (how many days/months of natural background exposure the procedure represents) rather than absolute millisievert values. A CT scan equating to '3.7 years of background radiation' is more meaningful to most patients than '10 mSv,' though both should be framed in the context of the diagnostic benefit.
알고 계셨나요?
Marie Curie, who discovered polonium and radium and was the first woman to win a Nobel Prize (and the only person to win Nobel Prizes in two different sciences — Physics in 1903 and Chemistry in 1911), almost certainly died in 1934 from aplastic anaemia caused by her decades of unprotected radiation exposure in the laboratory. Her original laboratory notebooks remain so radioactively contaminated that they are stored in lead-lined boxes at the National Library of France and visitors must sign a waiver before viewing them.
참고 자료
- ›ICRP Publication 103 — Recommendations of the ICRP (2007)
- ›BEIR VII Report — Health Risks from Exposure to Low Levels of Ionising Radiation (NAS, 2006)
- ›UK HPA — Radiation Dose Chart (Public Health England, 2011 updated)
- ›NCRP Report 160 — Ionising Radiation Exposure of the Population of the United States (2009)
- ›Image Gently Alliance — Radiation Safety in Paediatric Imaging